Latest Half Year Results News

Regis Healthcare reported a strong 18.4% revenue increase to $667.7 million for H1 2026, despite a 44.8% drop in statutory net profit. The company expanded its aged care portfolio through key acquisitions and declared a fully franked interim dividend.

EVT Limited reported a robust first half for 2026 with revenue rising 5.4% to A$683.8 million and net profit up 21.6%, driven by strong performances in Germany, Thredbo, and Hotels. Strategic acquisitions, including Pro-invest Hotels and QT Auckland, underpin the group’s growth ambitions.

Lendlease reported a statutory loss of $318 million for the half year ended December 2025, reflecting non-cash impairments, while its core Investments, Development and Construction segment delivered solid EBITDA and maintained full-year guidance. The group is focused on capital recycling and balance sheet strengthening ahead of anticipated earnings growth in FY27.

Nuix Limited has reported robust half-year results for 1H26, highlighted by a 148% increase in Nuix Neo Annualised Contract Value and a significant boost in profitability and cash flow.

GenusPlus Group Ltd has reported a record half-year with a 61% jump in revenue to $535.4 million and an 82% rise in net profit to $24.9 million, driven by strong performance across all business segments and strategic acquisitions. The company also declared its first-ever fully franked interim dividend of 2.0 cents per share.

Austal Limited reported a 21% rise in net profit to $30.5 million for H1 FY2026 on $1.11 billion revenue, yet declared no dividends amid a qualified audit.

Reece Limited reported a 6% rise in sales revenue to $4.6 billion for the half-year ending December 2025, while profits declined amid challenging market conditions. The company continues to expand its branch network in Australia and the US, balancing growth ambitions with cost pressures.

Perenti Limited reported steady half-year revenue of $1.73 billion with a 10.9% increase in net profit, underpinned by a $300 million Dalgaranga contract and growing drilling services in the US. The company also announced an unfranked interim dividend and a CEO transition underway.

Mesoblast Limited is set to release its half-year financial results and operational update, spotlighting its FDA-approved cell therapy and expanding international partnerships.

Aurora Labs reported a 15% revenue decline and a 12% increase in net loss for H1 2026, yet marked a strategic breakthrough with its first defence propulsion order and a successful $5.5 million capital raise.

N1 Holdings Limited reported a robust 64.7% increase in net profit after tax to $1.04 million for the half-year ended December 2025, driven by strong commercial lending growth and operational efficiencies. The company also expanded its committed lending capacity to over $355 million while maintaining a stable dividend.

Cadence Opportunities Fund Limited has reported a remarkable turnaround for the half-year ending December 2025, posting a $6.4 million profit and raising its interim dividend to 7.5 cents per share.